Orchestra Biomed Holdings Inc (OBIO) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Orchestra Biomed Holdings Inc   (NASDAQ: OBIO)
 

Orchestra Biomed Holdings Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Orchestra Biomed Holdings Inc 's inventory turnover ratio, the ratio that measures Orchestra Biomed Holdings Inc 's ability to manage its supply chain, sequentially decreased to 0.52 in the second quarter 2026, which does not come as a surprise, as the Orchestra Biomed Holdings Inc continue to experience headwinds, which also impact its supply chain. Orchestra Biomed Holdings Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 702 days, from 579 days, in the Mar 31 2026 quarter.

Within Healthcare sector 352 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1513 in the first quarter 2026, to 1872.

OBIO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Orchestra Biomed Holdings Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OBIO Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 35.14 % 105.19 % 79.19 % 55.98 % 164.29 %
Y / Y Cost of Sales Growth -45.65 % -27.27 % -12.07 % -27.94 % 4.55 %
Inventory Turnover Ratio (TTM) 0.52 0.63 0.76 0.92 1.19
OBIO's Total Ranking # 1872 # 1513 # 1613 # 1613 # 1567
Average inventory processing period 699 583 478 397 307
Seq. Inventory Growth -9.75 % -10.65 % -15.07 % 97.3 % 37.04 %
Seq. Cost of Sales Growth -21.87 % -37.25 % 4.08 % 6.52 % 4.55 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 156
Healthcare Sector # 353
Overall Market # 1872

Inventory Turnover Ratio Statistics
High Average Low
1.42 1.08 0.52
(Jun 30 2024)   (Jun 30 2026)



OBIO Company Profile >> Back to OBIO Efficiency Comparisons >> Compare OBIO Inventory Turnover Ratio to its Competitors

Financial Statements
Orchestra Biomed Holdings Inc 's Inventories $ 0 Millions Visit OBIO's Balance sheet
Orchestra Biomed Holdings Inc 's Cost of Revenues TTM $ 0 Millions Visit OBIO's Income Statement
What are OBIO's Sales? Visit OBIO's Sales by Segment

Other Inventory Turnover Ratios
Orchestra Biomed Holdings Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
OBIO's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for OBIO's Competitors
Inventory Turnover Ratio for OBIO's Suppliers
Inventory Turnover Ratio for OBIO's Customers

You may also want to know
OBIO's Sales Growth Rates OBIO's Pe Price to earnings ratio OBIO's Receivables Turnover Ratio OBIO's Stock Quote
OBIO's Net Income Growth Rates OBIO's Ps Price to Sales ratio OBIO's Sales per Employee OBIO's Asset Turnover Ratio
OBIO's Net Margin OBIO's Pb Price to Book ratio OBIO's Financial Strength Ratios OBIO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Vycor Medical Inc   1.72 $ 0.301  Millions$ 0  Millions
Harvard Bioscience Inc   1.71 $ 37.097  Millions$ 22  Millions
Quanterix Corporation  1.69 $ 87.760  Millions$ 52  Millions
Haemonetics Corporation  1.68 $ 553.577  Millions$ 329  Millions
Conmed Corporation  1.68 $ 606.349  Millions$ 362  Millions
Stryker Corp  1.67 $ 9,049.000  Millions$ 5,405  Millions
Atricure Inc   1.67 $ 134.975  Millions$ 81  Millions
Ceribell Inc   1.66 $ 11.159  Millions$ 7  Millions
The Cooper Companies Inc   1.65 $ 1,443.300  Millions$ 875  Millions
Procept Biorobotics Corporation  1.65 $ 120.119  Millions$ 73  Millions
Sanuwave Health Inc   1.62 $ 10.421  Millions$ 6  Millions
Bio rad Laboratories Inc   1.62 $ 1,245.200  Millions$ 769  Millions
Innovative Eyewear Inc   1.61 $ 2.634  Millions$ 2  Millions
Ultragenyx Pharmaceutical Inc   1.60 $ 87.336  Millions$ 55  Millions
Pfizer Inc  1.60 $ 17,084.000  Millions$ 10,684  Millions
Capsovision Inc   1.60 $ 5.736  Millions$ 4  Millions
Lakeland Industries Inc   1.59 $ 128.669  Millions$ 81  Millions
Integra Lifesciences Holdings Corp  1.59 $ 783.084  Millions$ 492  Millions
Ss Innovations International Inc  1.58 $ 28.689  Millions$ 18  Millions
Rapid Micro Biosystems Inc   1.57 $ 29.477  Millions$ 19  Millions
Urogen Pharma Ltd   1.54 $ 17.278  Millions$ 11  Millions
Bausch and Lomb Corp  1.54 $ 1,523.000  Millions$ 989  Millions
Staar Surgical Co  1.53 $ 79.388  Millions$ 52  Millions
Abeona Therapeutics Inc   1.51 $ 8.405  Millions$ 6  Millions
Enovis Corp  1.50 $ 898.682  Millions$ 601  Millions
Axogen inc   1.45 $ 63.909  Millions$ 44  Millions
Cv Sciences Inc   1.45 $ 5.804  Millions$ 4  Millions
Nuwellis Inc   1.43 $ 2.732  Millions$ 2  Millions
Mannkind Corporation  1.43 $ 55.824  Millions$ 39  Millions
Insmed Inc  1.43 $ 188.217  Millions$ 132  Millions

Date modified: 2026-09-08T21:23:06+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.